Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPhoenix Group Holdings Regulatory News (PHNX)

  • There is currently no data for PHNX

Internal Model Harmonisation Approval

14 Sep 2021 14:07

RNS Number : 7533L
Phoenix Group Holdings PLC
14 September 2021
 

LEI: 2138001P49OLAEU33T68

 

Phoenix Group's Internal Model Harmonisation application is approved by the PRA

 

The Board of Phoenix Group Holdings plc ("the Group") is pleased to announce that the Prudential Regulation Authority ("PRA") has approved its application to harmonise its legacy Phoenix and Standard Life internal models.

 

This single, more sophisticated harmonised Internal Model will provide deeper insights into our risk profile which further strengthens the Group's risk management approach and decision making, as well as delivering significant capital synergies through diversification and improved risk modelling.

 

The harmonised Internal Model will go live effective 30 September 2021 and is currently estimated to increase the Group's Solvency II ("SII") Surplus by c.£0.4 billion. It is expected that c.£0.1 billion of the increased SII Surplus will then emerge as an acceleration of cash in 2022, after an appropriate period of operation.

 

The harmonised Internal Model also delivers a reduced capital strain for the Group's Bulk Purchase Annuity ("BPA") new business and unlocks a wider pipeline of future management actions including the execution of Part VIIs, the delivery of further enhancements to the Group's credit risk modelling capabilities and the foundation to bring ReAssure onto the new Internal Model in time. It will also support the Group in delivering future value accretive M&A.

 

-------------------------------------------------------------------------------------------------------------------------------------------------------

Enquiries

Investors/analysts:

Claire Hawkins, Director of Corporate Affairs, Phoenix Group

+44 (0)20 3735 0575

Andrew Downey, Investor Relations Director, Phoenix Group

+44 (0)20 3735 0160

Media:

Douglas Campbell, Teneo

+44 (0)775 313 6628

Shellie Wells, Corporate Communications Director, Phoenix Group

+44 (0)20 3735 0922

-------------------------------------------------------------------------------------------------------------------------------------------------------

Legal Disclaimers

This announcement in relation to Phoenix and its subsidiaries (the "Group") contains forward-looking statements about the Group's current plans, goals and expectations relating to future financial events, conditions, performance, results, strategy and/or objectives. Statements containing the words: 'believes', 'intends', 'will', 'expects', 'may', 'should', 'plans', 'aims', 'seeks', 'continues', 'targets' and 'anticipates' or other words of similar meaning are forward-looking. Such forward-looking statements involve risk and uncertainty because they relate to future events and circumstances that are beyond the Group's control. As a result, such future events and the Group's actual future financial condition, performance and results may differ materially from the plans, goals and expectations set out in the forward-looking statements in this announcement. The Group undertakes no obligation to update any of the forward-looking statements contained within this announcement. References in this announcement to Solvency II Surplus should be read in conjunction with the relevant footnotes set out in the 2021 Half Year Results Announcement of 11 August 2021.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
REAGZGMLFDDGMZM
Date   Source Headline
25th Sep 20208:00 amRNSIntention to Vary the T&Cs of £500m RT1 Notes
8th Sep 20202:45 pmRNSDirector/PDMR Shareholding
28th Aug 20202:00 pmRNSTotal Voting Rights
17th Aug 20206:00 pmRNSDirector/PDMR Shareholding
11th Aug 20203:00 pmRNSDirector/PDMR Shareholding
7th Aug 202011:50 amRNSDirector/PDMR Shareholding
6th Aug 20202:15 pmRNSDirector/PDMR Shareholding
6th Aug 20207:00 amRNS2020 Half-Year Results
31st Jul 20204:00 pmRNSTotal Voting Rights
27th Jul 20204:00 pmRNSHolding(s) in Company
27th Jul 20204:00 pmRNSHolding(s) in Company
24th Jul 20204:30 pmRNSHolding(s) in Company
24th Jul 20204:00 pmRNSHolding(s) in Company
23rd Jul 20204:00 pmRNSHolding(s) in Company
23rd Jul 20204:00 pmRNSHolding(s) in Company
23rd Jul 202010:00 amRNSTotal Voting Rights
22nd Jul 20205:12 pmRNSCompletion of acquisition of ReAssure Group plc
22nd Jul 20203:15 pmRNSHolding(s) in Company
17th Jul 20204:15 pmRNSHolding(s) in Company
8th Jul 20209:00 amRNSDirector/PDMR Shareholding
6th Jul 20201:50 pmRNSDirector Declaration
1st Jul 20204:00 pmRNSDirector/PDMR Shareholding
30th Jun 20202:00 pmRNSTotal Voting Rights
29th Jun 20204:00 pmRNSDirector/PDMR Shareholding
24th Jun 20204:46 pmRNSHolding(s) in Company
19th Jun 20202:00 pmRNSBlock listing Return
17th Jun 20204:30 pmRNSHolding(s) in Company
9th Jun 20204:00 pmRNSDirector/PDMR Shareholding
8th Jun 20201:00 pmRNSDirector/PDMR Shareholding
4th Jun 202011:00 amRNSBlock Listing Application
3rd Jun 20202:00 pmRNSDirector/PDMR Shareholding
2nd Jun 20203:45 pmRNSPublication of Final Terms
29th May 20203:00 pmRNSDirector/PDMR Shareholding
29th May 20202:00 pmRNSTotal Voting Rights
28th May 20204:00 pmRNSDirector/PDMR Shareholding
28th May 20207:00 amRNSPhoenix Group Holdings plc issue of Tier 2 Notes
26th May 20203:00 pmRNSDirector/PDMR Shareholding
26th May 20203:00 pmRNSPublication of Suppl.Prospcts
22nd May 202012:30 pmRNSDirector/PDMR Shareholding
15th May 202012:55 pmRNSResult of AGM
12th May 20208:30 amRNSHolding(s) in Company
11th May 20202:00 pmRNSDirector/PDMR Shareholding
11th May 20201:59 pmRNSDirector/PDMR Shareholding
11th May 20201:50 pmRNSPublication of Supplemental Prospectus
7th May 202010:20 amRNSPhoenix's Cap Position Supports 2019 Div Payment
30th Apr 202012:30 pmRNSTotal Voting Rights
27th Apr 20201:00 pmRNSPublication of Final Terms
22nd Apr 20205:15 pmRNSHolding(s) in Company
21st Apr 20204:31 pmRNSPublication of Supplemental Prospectus
21st Apr 20203:30 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.